Related Experiment Videos
[Complications of endocardial biopsy in heart transplant patients]
11st Department of Surgery, Hiroshima University School of Medicine, Japan.
Insights
Endomyocardial biopsy is a safe and effective method for diagnosing cardiac allograft rejection, with a low complication rate. This cardiac transplant monitoring technique has minimal long-term impact on patients.
Area of Science:
- Cardiology
- Transplantation Medicine
- Medical Procedures
Context:
- Endomyocardial biopsy is the gold standard for diagnosing cardiac allograft rejection.
- The study reviewed 2,894 biopsies from 183 heart transplant patients between 1986 and 1994.
- Assessing complication rates is crucial for procedural safety and patient outcomes.
Purpose:
- To evaluate the safety and complication profile of endomyocardial biopsy in heart transplant recipients.
- To determine the incidence and types of complications associated with the procedure.
- To compare complication rates with previous studies or different patient populations.
Summary:
- A total of 53 complications (1.8%) were recorded, with most minor.
- Introduction-related complications included carotid puncture (0.9%) and pneumothorax (0.1%).
- Intra-biopsy complications involved arrhythmias (0.4%) and ventricular perforation (0.2%), with no severe outcomes.
Impact:
- Endomyocardial biopsy demonstrates a low complication rate, supporting its continued use in monitoring heart transplant rejection.
- The findings indicate that the procedure is safe, with no significant long-term sequelae observed.
- This reinforces endomyocardial biopsy as a vital diagnostic tool in cardiac transplantation management.
Abstract:
Despite the increasing use of alternative techniques, endomyocardial biopsy remains the primary method for diagnosing cardiac allograft rejection. Between March 1986 and May 1994, 2,894 endomyocardial biopsies performed on 183 heart transplant patients were reviewed. A total of 53 (1.8%) complications occurred. 33 (1.1%) complications were associated with the introduction, including carotid puncture (0.9%), neurological reaction (0.1%), and pneumothorax (0.1%). Complications during biopsy included arrhythmias (0.4%) and ventricular perforation (0.2%). In addition, we observed three episodes of allergic reaction to a reusable biotome, three episodes of liver biopsy, and one case of pacemaker dislodgement. All complications were without significant long-term sequelae. In contrast to the cardiomyopathy population, no severe ventricular perforations or deaths occurred. Thus although endomyocardial biopsy has some risk, it continues to be a safe and effective way of monitoring rejection.